$PPCH will get a lot of attention from its upcoming feature in Sunday's edition of the New York Times; a perfect set up as they will be presenting to over 600 investors at a conference on May 28 as well as potential FDA approval for human drug trials. The past few days have shown very strong investor confidence. This is still a good time to buy; great support behind you and great potential ahead of you! http://finance.yahoo.com/news/propanc-present...00184.html